Page last updated: 2024-11-03

procarbazine and Franklin Disease

procarbazine has been researched along with Franklin Disease in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takano, H1
Nagata, K1
Mikoshiba, M1
Nakane, M1
Kato, A1
Hamaguchi, H1
Schubert, JC1

Other Studies

2 other studies available for procarbazine and Franklin Disease

ArticleYear
Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.
    American journal of hematology, 2008, Volume: 83, Issue:12

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic

2008
[Therapy of Waldenstrom's disease and of heavy chain disease].
    Hamatologie und Bluttransfusion, 1976, Volume: 18

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chlorambucil; Cyclophosphamide; Drug Therapy,

1976